More than 27% ESCC patients had somatic mutations in DNA-repair pathway genes, including BRCA2 (3%), TDG (3%), FANCM (3%), RIF (3%), and ATM (3%). This evidence concerns the gene TDG and esophageal squamous cell carcinoma.